Fidelity Investments’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Fidelity Investments’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,953	Closed	-$7.91K	–	5820
2023 Q4	$7.91K	Buy	1,953 +1,198	+159%	+$3.65K	﹤0.01%	4308
2023 Q3	$2.03K	Sell	755 -804,886	-100%	-$3.15M	﹤0.01%	4536
2023 Q2	$7.52M	Sell	805,641 -308,021	-28%	-$3.04M	﹤0.01%	1949
2023 Q1	$9.89M	Sell	1,113,662 -1,384,693	-55%	-$13.6M	﹤0.01%	1876
2022 Q4	$12.4M	Sell	2,498,355 -2,304,885	-48%	-$13.5M	﹤0.01%	1809
2022 Q3	$27.9M	Sell	4,803,240 -380,123	-7%	-$2.69M	﹤0.01%	1491
2022 Q2	$28.7M	Sell	5,183,363 -374,084	-7%	-$3.09M	﹤0.01%	1501
2022 Q1	$64.1M	Buy	5,557,447 +108,778	+2%	+$1.16M	0.01%	1292
2021 Q4	$69.1M	Buy	+5,448,669	New	+$82.3M	0.01%	1279

Fidelity Investments's THRX Position: Q1 2024 in Review

Fidelity Investments sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 1,953 shares — an estimated $7.91K sold.

Fidelity Investments first reported a position in THRX in Q4 2021 and held it in 9 quarters. The position peaked at $69.1M in Q4 2021. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

Fidelity Investments reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Fidelity Investments sold 1,953 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $7.91K.
Fidelity Investments first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
Fidelity Investments's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $69.1M in Q4 2021.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Fidelity Investments's 13F filing for Q1 2024, filed 13 May 2024.